Sign in

CIK 0001962011 · <br>Emerging growth company

Kairos Pharma, LTD.

Sign in to watch
Ticker
KAPA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
462993314
Phone
818-404-5541
Business address
2355 WESTWOOD BLVD. #139, LOS ANGELES, CA, 90064
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 8-K Event Regulation FD disclosure
  4. 10-Q Report Quarterly Report
  5. 8-K Event Other events
  6. 8-K Event Material agreement
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 8-K Event Material agreement
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Material agreement · Other events
  17. 8-K Event Material agreement · Regulation FD disclosure
  18. 424B4 Offering Prospectus
  19. EFFECT Other Notice of Effectiveness
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 5 of 7 · 125 filings